Abstract

Extracellular vesicles (EVs) are small membrane-enclosed particles released by cells under various conditions specific to cells’ biological states. Hence, mass-spectrometry (MS) based proteome analysis of EVs in plasma has gained much attention as a method to discover novel protein biomarkers. MS analysis of EVs in plasma is challenging and EV isolation is usually necessary. Therefore, we compared differences in abundance, subtypes, and contamination for EVs isolated by high-speed centrifugation, size exclusion chromatography (SEC), and peptide-affinity precipitation (PAP/ME kit) for subsequent MS-based proteome analysis. Successful EV isolation was evaluated by nanoparticle-tracking analysis, immunoblotting, and transmission electron microscopy, while EV abundance, EV subtypes, and contamination was evaluated by label-free tandem MS. High-speed centrifugation and SEC isolates showed high EV abundance at the expense of contamination by non-EV proteins and lipoproteins, respectively. These two methods also resulted in EVs of a similar type, however, with smaller EVs in SEC isolates. PAP isolates had a relatively low EV abundance and high contamination. We consider high-speed centrifugation and SEC suitable as EV isolation for MS biomarker studies, where the choice between the two should depend on the scientific questions and whether the focus is on larger or smaller EVs or a combination of both.

Highlights

  • Blood plasma is a minimally-invasive source for discovering protein biomarkers for disease diagnostics, screening, monitoring, and evaluation of therapeutic responses [1,2]

  • EVisolates isolateswere were by nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), immunoblotting, characterized by nanoparticle tracking analysis (NTA), transmission electron microscopy characterized by nanoparticle tracking analysis (NTA), transmission electron microscopy(TEM), (TEM), and mass spectrometry (MS)

  • We evaluated and compared three different extracellular vesicles (EVs) isolation protocols for their applicability in MS proteome-based biomarker research

Read more

Summary

Introduction

Blood plasma is a minimally-invasive source for discovering protein biomarkers for disease diagnostics, screening, monitoring, and evaluation of therapeutic responses [1,2]. MS can analyse and quantify thousands of proteins in an unbiased way covering 5–6 orders of magnitude in protein abundances. As plasma proteins span more than 12 orders of magnitude, MS is limited to analysis of only the most abundant proteins in non-processed plasma [3]. Focusing the analysis on extracellular vesicles (EVs) contained within plasma is a new diagnostic possibility, enabling the analysis of protein biomarkers despite the complexity of plasma.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call